Millions of breast cancer patients could be spared chemotherapy thanks to groundbreaking gene test

A study that followed more than 4,400 patients aged 40 and over found chemotherapy had 'little or no additional benefit' to people whose tumours had a low Prosigna test score.

More from Daily News